Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-020788
Filing Date
2026-04-30
Accepted
2026-04-30 20:16:43
Documents
2
Period of Report
2026-04-27

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2376
2 EX-24.1 ex24-1.htm EX-24.1 26114
  Complete submission text file 0001493152-26-020788.txt   30158
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Issuer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CDT EQUITY INC. 4851 TAMIAMI TRAIL NORTH, SUITE 200 NAPLES FL 34103
Business Address
Olsen Ulrik K (Reporting) CIK: 0002132215 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41245 | Film No.: 26928345